Chirag Desai | Professor Of Surgery, Director, Chronic Pancreatitis And Autologous-Islet Cell Transplant Program
University Of North Carolina School Of Medicine

Chirag Desai, Professor Of Surgery, Director, Chronic Pancreatitis And Autologous-Islet Cell Transplant Program, University Of North Carolina School Of Medicine

Chirag Desai, MD is an abdominal organ transplant and hepatobiliary-pancreatic surgeon with special interest in the field of chronic pancreatitis and autologous islet cell transplantation.
He was trained in General Surgery in India at the King Edward Memorial Hospital in Mumbai, the largest tertiary care center in India. He was an attending surgeon at the same institute between 2003 and 2006. Dr. Desai moved to the United States in 2006 and worked as a visiting physician in the Transplantation Institute at the Mount Sinai School of Medicine. Between 2007 and 2010, he did his abdominal organ transplant surgery fellowship at the Georgetown University Hospital in Washington, DC.
Dr. Desai has been an active member of surgical teams at various institutions including serving as an Assistant Professor of Surgery at the University of Arizona, where he was involved in starting a new intestinal transplant program. He returned to Georgetown University Hospital and its Transplant Institute, where he was the founding director of an autologous islet cell transplant program and was promoted to Associate Professor of Surgery. He received a research grant from National Pancreatic Foundation in 2015, for studying islet engraftment in different liver models. 
He moved to the University of North Carolina at Chapel Hill in 2016 as Surgical Director of liver transplantation, initiating a new Chronic Pancreatitis and autologous islet cell transplant program which he currently directs. The program emphasis is on recurrent and chronic pancreatitis as well as islet cell autotransplantation, along with other complex pancreatic disorders.
He has published several manuscripts in the field in the prestigious journals including but not limited to American Journal of Transplantation, Transplantation, Pediatric Transplantation, Journal of the American College of Surgeons, JAMA Surgery and Islets. He is member of several transplant and hepatobiliary-pancreatic surgery committees.


Conference Day 2 - Wednesday 1st April 2020 @ 11:20

Challenges and Troubleshooting of starting auto-islet cell transplant program

  • Institutional, Financial and administrative challenges
  • Clinical challenges with different providers and patients
  • Different options and broad cost analysis of putting together facility and islet isolation team

Conference Day 2 - Wednesday 1st April 2020 @ 12:20

Exosome derived from peripheral blood plasma of chronic pancreatitis patients and healthy volunteers and explore therapeutic potential in auto-islet transplant

  • Produce and characterize serum derived exosome products from CP and healthy subjects and to establish the feasibility of cGMP-compliant production.
  • Evaluate if CP patient derived exosome has impaired anti-inflammatory response by comparing the exosome molecular profile and potency with healthy individuals.
  • Evaluate in mouse model therapeutic potential
last published: 21/Jan/20 11:25 GMT

back to speakers